Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis

NCT01680159 is registered in ClinicalTrials.gov with Tanabe Pharma Corporation as lead sponsor.

NCT NCT01680159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01680159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
Lead sponsor
Tanabe Pharma Corporation
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2012
Completion date
March 31, 2015
Enrollment
51 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis, psoriatic arthritis, psoriatic erythroderma, pustular psoriasis (excluding a localized)